9 abril 2015
The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests ‘we are finally poised to deliver curative therapies to cancer patients,’ researchers state in a new report that covers the strengths and weaknesses of the two forms of therapy and notes how their combination could be particularly potent.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ky3a253xU0w/150409133519.htm
